These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12351967)

  • 1. Efficacy and safety of fluvastatin in hyperlipidemic protease inhibitor-treated HIV-infected patients.
    Doser N; Kübli S; Telenti A; Marzolini C; Chave JP; Feihl F; Buclin T; Pannatier A; Darioli R; Nicod P; Waeber B; Mooser V
    AIDS; 2002 Sep; 16(14):1982-3. PubMed ID: 12351967
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid lowering therapy with fluvastatin and pravastatin in patients with HIV infection and antiretroviral therapy: comparison of efficacy and interaction with indinavir.
    Benesic A; Zilly M; Kluge F; Weissbrich B; Winzer R; Klinker H; Langmann P
    Infection; 2004 Aug; 32(4):229-33. PubMed ID: 15293079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of metabolic disorders with fluvastatin after renal transplantation.
    Podder H; Gerõ L; Földes K; Szabó J; Lazar N; Járay J
    Transplant Proc; 1997; 29(1-2):216-9. PubMed ID: 9122968
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of treatment with low-dose fluvastatin in hypercholesterolemic renal transplant recipients.
    Akiyama T; Ishii T; Imanishi M; Nishioka T; Matsuura T; Kurita T
    Transplant Proc; 2001 May; 33(3):2115-8. PubMed ID: 11377469
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluvastatin for lowering cholesterol.
    Med Lett Drugs Ther; 1994 May; 36(923):45-6. PubMed ID: 8177137
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute cholestasis during long-term treatment with fluvastatin in a nephrotic patient.
    Gascón A; Zabala S; Iglesias E
    Nephrol Dial Transplant; 1999 Apr; 14(4):1038. PubMed ID: 10328507
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of fluvastatin in patients with non-insulin-dependent diabetes mellitus and hyperlipidemia: preliminary report.
    Knopp RH; Frolich JJ
    Am J Cardiol; 1994 May; 73(14):39D-41D. PubMed ID: 8198023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvastatin in renal transplantation.
    Hadjigavriel M; Kyriakides G
    Transplant Proc; 1997 Nov; 29(7):3050. PubMed ID: 9365661
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of fluvastatin on lipoprotein profiles in treating renal transplant recipients with dyslipoproteinemia.
    Li PK; Mak TW; Chan TH; Wang A; Lam CW; Lai KN
    Transplantation; 1995 Oct; 60(7):652-6. PubMed ID: 7570971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of fluvastatin in patients with non-insulin-dependent diabetes mellitus and hyperlipidemia.
    Knopp RH; Frohlich J; Jokubaitis LA; Dawson K; Broyles FE; Gomez-Coronado D
    Am J Med; 1994 Jun; 96(6A):69S-78S. PubMed ID: 8017470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of fluvastatin in hypercholesterolemia in renal transplant recipients.
    Ghods AJ; Milanian I; Arghani H; Ghadiri G
    Transplant Proc; 1995 Oct; 27(5):2579-80. PubMed ID: 7482835
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluvastatin versus pravastatin.
    Chilton R
    Am J Cardiol; 1996 Jul; 78(1):127. PubMed ID: 8712106
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of fluvastatin in cardiovascular risk management.
    McDonald KJ; Jardine AG
    Expert Opin Pharmacother; 2008 Jun; 9(8):1407-14. PubMed ID: 18473714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study.
    Baldini F; Di Giambenedetto S; Cingolani A; Murri R; Ammassari A; De Luca A
    AIDS; 2000 Jul; 14(11):1660-2. PubMed ID: 10983656
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fluvastatin in a comparative study. Are there substance-specific differences between various CSE-inhibitors?].
    Internist (Berl); 1999 Mar; 40(3 Suppl Gibt Es):1-4. PubMed ID: 10192028
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics and lipid-lowering effect of fluvastatin in hypercholesterolaemic patients on maintenance haemodialysis.
    Ichimaru N; Takahara S; Moriyama T; Kondo M; Nonomura N; Tanaka T; Wang JD; Imai E; Okuyama A; Kondo Y
    J Int Med Res; 2004; 32(1):45-52. PubMed ID: 14997705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term event monitoring study of fluvastatin in Japanese patients with hypercholesterolemia: Efficacy and incidence of cardiac and other events in elderly patients (≥ 65 years old).
    Itakura H; Nakaya N; Kusunoki T; Shimizu N; Hirai S; Mochizuki S; Ishikawa T
    J Cardiol; 2011 Jan; 57(1):77-88. PubMed ID: 21067897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvastatin in primary hypercholesterolemia: efficacy and safety in patients at high risk. An analysis of a clinical trial database.
    Peters TK; Muratti EN; Mehra M
    Am J Med; 1994 Jun; 96(6A):79S-83S. PubMed ID: 8017471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary report of the safety and efficacy of fluvastatin for hypercholesterolemia in renal transplant patients receiving cyclosporine.
    Goldberg RB; Roth D
    Am J Cardiol; 1995 Jul; 76(2):107A-109A. PubMed ID: 7604782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluvastatin exposure during pregnancy.
    Seguin J; Samuels P
    Obstet Gynecol; 1999 May; 93(5 Pt 2):847. PubMed ID: 10912423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.